Pharmaceutical Innovation: Law & the Public's Health-Reference-Cited by-同舟云学术

Pharmaceutical Innovation: Law & the Public's Health

Published:2009 Issue:2 Volume:37 Page:173-175
ISSN:1073-1105
Container-title:Journal of Law, Medicine & Ethics
language:en
Short-container-title:J. Law. Med. Ethics

Author:

Outterson Kevin

Publisher

Cambridge University Press (CUP)

Subject

Health Policy,General Medicine,Issues, ethics and legal aspects

Link

http://journals.sagepub.com/doi/pdf/10.1111/j.1748-720X.2009.00363.x

Reference16 articles.

1. Compulsory Licensing in Canada and Thailand: Comparing Regimes to Ensure Legitimate Use of the WTO Rules

2. Prizes and Parasites: Incentive Models for Addressing Chagas Disease

3. 1. IMS Health Lowers 2009 Global Pharmaceutical Market Forecast to 2.5 – 3.5 Percent Growth, Press Release, April 22, 2009, available at (last visited May 6, 2009).

4. Developing Nations and the Compulsory License: Maximizing Access to Essential Medicines While Minimizing Investment Side Effects

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Compulsory licensing of patents;Information & Communications Technology Law;2016-09

2. Testimony of Kevin Outterson (Boston University School of Law) to the House Energy and Commerce Committee, September 19, 2014;SSRN Electronic Journal;2014

3. The ‘Myth’ of Patent Justifications: Triumph and Failure Dichotomy in the North and South;Patenting of Pharmaceuticals and Development in Sub-Saharan Africa;2012-09-12

4. Impact of the Australia—US Free Trade Agreement on Australian Medicines Regulation and Prices;Journal of Generic Medicines: The Business Journal for the Generic Medicines Sector;2010-01